Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C-11 Acetate PET/CT in High Grade Glioma
NCT01961934Phase 3Withdrawn
- Sponsor
- Phoenix Molecular Imaging
- Start
- May 2014
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of carbon-11 acetate in glioma, sponsored by Phoenix Molecular Imaging. Primary endpoint: Biopsy Correlation at 3 weeks. Planned start May 2014; status: withdrawn.
02
Drugs
carbon-11 acetate
03
Conditions
glioma
Beyond the preview
Go deeper on NCT01961934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01961934.